Safety and effect of biphasic insulin aspart 50 [insulin aspart/insulin protamine aspart] compared to biphasic human insulin 50 [insulin suspension isophane/insulin] in patients with type 2 diabetes mellitus.
Phase of Trial: Phase III
Latest Information Update: 03 Dec 2014
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin suspension isophane/insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 20 May 2009 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
- 20 May 2009 Planned number of patients changed from 75 to 81 as reported by ClinicalTrials.gov.
- 07 Dec 2007 Status change from recruiting to completed.